This position will lead globalpricing and reimbursement strategy for Sutimlimab in Cold Agglutinin Disease,an orphan condition, and its follow on indications. This role will report tothe Head of Pricing Strategy. The Lead will develop the global market accessstrategy to optimize pricing and access scenarios in alignment with the brandstrategy. This global role covers various payer systems and requiresestablishment of strong cross functional relationships in a matrix environment.
Key Responsibilities including butnot limited to:
Support development of Pricing and Access strategies to best prepare for launch by creating an optimal pricing, reimbursement, market access environment for Sutimlimab in Cold Agglutinin Disease
Support market access activities for follow-on indications of Sutimlimab through identification of and influencing clinical trial endpoints, product positioning, TPP by providing strategic input for value story development to enable maximizing reimbursement and access potential
Partner effectively with global functions such as Commercial, Decision Support, Clinical Development, Medical, HEOR, regions and countries as needed to align on and execute on Market Access strategies and deliverables
Contribute to the development of Global pricing guidance for Sutimlimab to enable successful regional and affiliate execution
Develop footprint optimization and launch sequencing strategies
Collaborate with Regional and Local market access teams to support early advice, payer research, or payer advisory boards
Provide pricing and access focused inputs for forecasting activities including gross to net
Ensure development of required Market Access Tools to support launch pricing and access readiness
Continuously monitor and coordinate response strategies to ensure appropriate and timely country support
Must be open-minded and nimble to drive innovative solutions to meet payer unmet needs
Strong analytical abilities, including taking incomplete information and develop impactful insights
Experience preparing for a global launch including assessing opportunities and threats to launch sequencing, international reference pricing, and developing global pricing policies
Strong technical understanding of pricing, reimbursement and access methods
Understanding of key local healthcare systems
Understanding of rare and orphan diseases desirable
Applicant must have excellent organizational and project management. In addition, effective communication with peers and senior level executives
Previous experience with business strategy, consulting, finance or market access disciplines including pricing and reimbursement preferred
Bachelor's degree required. Master's or advanced degree preferred. 8+ years of pharmaceutical experience, with at least 5 years in market access
Bioverativ, a Sanofi company, is dedicated to transforming the lives of people with hemophilia and other rare blood disorders. We have a leading portfolio of hemophilia therapies and an innovative pipeline of programs in hemophilia, cold agglutinin disease, sickle cell disease and beta thalassemia.
We believe that great science conquers the toughest medical obstacles, and we are inspired to push scientific boundaries to make a meaningful impact in the lives of people with rare blood disorders. Formed by a spin-off of Biogen's hemophilia business in 2017, we bring a strong legacy of innovation, world-class science, and commitment to the blood disorders community. We are united by a singular purpose: to create progress where patients need it most.
With nearly 400 people and robust capabilities from discovery to commercialization, our vision is to become the leading hematology rare disease company.
Weare an equal opportunity employer. We evaluate qualified applicants withoutregard to race, color, religion, sex, sexual orientation, genderidentity, national origin, disability, veteran status, or anyother protected characteristic.
WeRequest Priority Protected Veteran and Disabled Referrals for all ourlocations.
Bioverativ is an E-VerifyEmployer in the United States.